Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559680775> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2559680775 endingPage "4670" @default.
- W2559680775 startingPage "4670" @default.
- W2559680775 abstract "Abstract Abstract 4670 Background: Acute Hemolytic Reactions (AHR) and Intravascular Hemolysis (IVH) have been reported rarely with Rh (D) Immune Globulin (WinRho® SDF) administration for normalization of platelet count in ITP. The sporadic and unpredictable occurrence of these events has led to an analysis of our WinRho® SDF safety database to identify populations that may be at higher risk for occurrence of AHR's. A disproportionality analysis revealed that malignancies were disproportionally over represented in cases with AHR compared to Non Hemolytic Reactions and was reported in another abstract. Aims: To determine which malignancies were disproportionally overrepresented in patients who developed AHR's. Methods: Medical Histories cases with AHR with malignancies were reviewed and classified by type of malignancy. AHR's included both the expected post infusion hemolysis and infrequently reported cases involving clinically compromising hemolysis including IVH. Hematological malignancies were present in 39/45 of AHR's (86.6 %) and non-hematological malignancies 6 of 45 of AHR (13.3%). 90% of AHR's in patients with Malignancies were adult, 5% children and 5% age unknown. Adults above the age of 65 years accounted for 45% of these cases. CLL was present in 66% of patients with leukemia and Non Hodgkins Lymphoma was present in 92% of patients with Lymphomas. Proliferative disorders were diagnosed in 27% of patients with AHR. Solid tumors were present in 14% of patients with AHR's. Conclusions: Hematological malignancies including CLL and NHL are disproportionally over represented in cases presenting with AHR post WinRho® SDF. Alternate therapies to Rh (D) Immune Globulin should be considered in patients with thrombocytopenia and these hematological malignancies due to increased risk of AHR, such as IVH. Disclosures: Astacio: Cangene Corporation: Employment. Muller:Cangene Corporation: Employment. Little:Cangene Corporation: Employment. Sinclair:Cangene Corporation: Employment. Genereux:Cangene Corporation: Employment." @default.
- W2559680775 created "2016-12-08" @default.
- W2559680775 creator A5002275980 @default.
- W2559680775 creator A5039555582 @default.
- W2559680775 creator A5047160531 @default.
- W2559680775 creator A5062024478 @default.
- W2559680775 creator A5077377880 @default.
- W2559680775 date "2010-11-19" @default.
- W2559680775 modified "2023-09-27" @default.
- W2559680775 title "Which Hematological Malignancies Are Implicated In Acute Hemolytic Reactions Following Rh (D) Immune Globulin for ITP" @default.
- W2559680775 doi "https://doi.org/10.1182/blood.v116.21.4670.4670" @default.
- W2559680775 hasPublicationYear "2010" @default.
- W2559680775 type Work @default.
- W2559680775 sameAs 2559680775 @default.
- W2559680775 citedByCount "0" @default.
- W2559680775 crossrefType "journal-article" @default.
- W2559680775 hasAuthorship W2559680775A5002275980 @default.
- W2559680775 hasAuthorship W2559680775A5039555582 @default.
- W2559680775 hasAuthorship W2559680775A5047160531 @default.
- W2559680775 hasAuthorship W2559680775A5062024478 @default.
- W2559680775 hasAuthorship W2559680775A5077377880 @default.
- W2559680775 hasConcept C126322002 @default.
- W2559680775 hasConcept C203014093 @default.
- W2559680775 hasConcept C2776863199 @default.
- W2559680775 hasConcept C2778461978 @default.
- W2559680775 hasConcept C2779338263 @default.
- W2559680775 hasConcept C2779399171 @default.
- W2559680775 hasConcept C2779902561 @default.
- W2559680775 hasConcept C71924100 @default.
- W2559680775 hasConcept C90924648 @default.
- W2559680775 hasConceptScore W2559680775C126322002 @default.
- W2559680775 hasConceptScore W2559680775C203014093 @default.
- W2559680775 hasConceptScore W2559680775C2776863199 @default.
- W2559680775 hasConceptScore W2559680775C2778461978 @default.
- W2559680775 hasConceptScore W2559680775C2779338263 @default.
- W2559680775 hasConceptScore W2559680775C2779399171 @default.
- W2559680775 hasConceptScore W2559680775C2779902561 @default.
- W2559680775 hasConceptScore W2559680775C71924100 @default.
- W2559680775 hasConceptScore W2559680775C90924648 @default.
- W2559680775 hasIssue "21" @default.
- W2559680775 hasLocation W25596807751 @default.
- W2559680775 hasOpenAccess W2559680775 @default.
- W2559680775 hasPrimaryLocation W25596807751 @default.
- W2559680775 hasRelatedWork W122023798 @default.
- W2559680775 hasRelatedWork W1968411866 @default.
- W2559680775 hasRelatedWork W2013647965 @default.
- W2559680775 hasRelatedWork W2050861331 @default.
- W2559680775 hasRelatedWork W2085330591 @default.
- W2559680775 hasRelatedWork W2091475762 @default.
- W2559680775 hasRelatedWork W2160848167 @default.
- W2559680775 hasRelatedWork W2358268857 @default.
- W2559680775 hasRelatedWork W2408943424 @default.
- W2559680775 hasRelatedWork W2428449797 @default.
- W2559680775 hasVolume "116" @default.
- W2559680775 isParatext "false" @default.
- W2559680775 isRetracted "false" @default.
- W2559680775 magId "2559680775" @default.
- W2559680775 workType "article" @default.